Technical Analysis for BTI - biOasis Technologies Inc.

Grade Last Price % Change Price Change
F 0.005 -99.60% -1.255
BTI closed down 99.6 percent on Monday, November 4, 2024, on 48 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 200 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
New Downtrend Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -99.60%
Crossed Above 20 DMA Bullish -99.60%
Crossed Above 200 DMA Bullish -99.60%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

biOasis Technologies Inc. Description

biOasis Technologies Inc. is a development-stage biopharmaceutical company, which is focused on research, development and commercialization of technologies and products that are intended for the treatment of central nervous system (CNS) diseases and diseases of the brain. The Company researches and develops products for diagnosis and treatment of neurological diseases and disorders. It is engaged in the development of its vectors Transcend and Transcendpep for the transport of therapeutic agents across the blood brain barrier (BBB). The Transcend brain delivery platform exploits the BBB penetrating properties of a recombinant soluble human protein known as melanotransferrin (MTf or p97) and portions thereof. Transcend delivery molecules have the ability to transport a range of molecules across the BBB. The Company owns approximately 30 the United States and foreign patents/applications related to p97 as a BBB delivery vector and as a biomarker for Alzheimer's disease.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Transport Medicine Pharma Pharmaceutical Delivery Disease Biology Biopharmaceutical Diseases Disorders Alzheimer's Disease Neurological Diseases Neurology Biomarker Brain Central Nervous System Nervous System

Is BTI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.29
52 Week Low 0.005
Average Volume 132,162
200-Day Moving Average 0.418
50-Day Moving Average 0.992
20-Day Moving Average 0.688
10-Day Moving Average 0.379
Average True Range 0.293
RSI (14) 40.83
ADX 36.09
+DI 39.871
-DI 57.791
Chandelier Exit (Long, 3 ATRs) 0.391
Chandelier Exit (Short, 3 ATRs) 0.884
Upper Bollinger Bands 1.922
Lower Bollinger Band -0.547
Percent B (%b) 0.22
BandWidth 359.185
MACD Line -0.230
MACD Signal Line -0.191
MACD Histogram -0.0389
Fundamentals Value
Market Cap 339.82 Thousand
Num Shares 68 Million
EPS -0.06
Price-to-Earnings (P/E) Ratio -0.09
Price-to-Sales 5.40
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.005
Resistance 3 (R3) 0.005 0.005 0.005
Resistance 2 (R2) 0.005 0.005 0.005 0.005
Resistance 1 (R1) 0.005 0.005 0.005 0.005 0.005
Pivot Point 0.005 0.005 0.005 0.005 0.005
Support 1 (S1) 0.005 0.005 0.005 0.005 0.005
Support 2 (S2) 0.005 0.005 0.005 0.005
Support 3 (S3) 0.005 0.005 0.005
Support 4 (S4) 0.005